Around the Practice

In collaboration with Urology Times ®, LUGPA offers members the opportunity to register and participate in a MONTHLY interactive virtual forum. Attendees can discuss, ask questions, submit and present cases across all GU malignancies.  The case-based format will provide the opportunity to share knowledge and best practices in managing challenging cases. This multi-disciplinary program will be co-moderated by Raoul S. Concepcion, MD (Nashville TN) and Jason Hafron, MD (Troy MI), and include discussants from urology, pathology, radiation oncology and medical oncology.


Raoul S. Concepcion, MD
U.S. Urology Partners
Nashville, TN

Jason Hafron, MD
Michigan Institute of Urology
Troy, MI



September 15, 2021  -  5 PM ET 

Cases to be discussed:


  • Lymphocele management after prostatectomy
  • Post radical prostatectomy, adjuvant radiation: with bladder neck contracture and incontinence
  • TBD


Register here for September 15

October 20, 2021  -  5 PM ET 

Cases to be discussed:

  • Metastatic Castrate-Sensitive Prostate Cancer Treated With Combination Therapy

  • Young adult with newly diagnosed high-grade, high-risk prostate cancer


Register here for Oct. 20



January 20, 2021
Hear from key opinion leaders in the urology space as they discuss 2 complex cases across the multidisciplinary approach in upper tract urothelial carcinoma and an incidentally discovered renal mass.

  • Upper Tract Urothelial Carcinoma
  • Incidentally discovered Renal mass and the role of biopsy and molecular testing

Watch On Demand Here.

February 17, 2021  

  • Incidentally discovered adrenal mass.
  • Localized prostate cancer, high risk disease with oligometastasis at diagnosis.

Watch On Demand Here

March 24, 2021 

  • Penile/Urethral cancer with inguinal adenopathy
  • Non-muscle Invasive Bladder/Urothelial Cancer (NMIBC), BCG unresponsive

Watch On Demand Here  



April 21, 2021  

  • mCRPC, failed or not tolerated docetaxel  
  • High-risk RCC following resection

 Watch On Demand Here 



May 19, 2021 


  • PARP inhibitor for the treatment of metastatic castrate resistant prostate cancer
  • Immunotherapy monotherapy for the treatment of BCG-unresponsive non-muscle invasive bladder cancer
  • Novel hormone therapy for the treatment of non-metastatic castrate resistant prostate cancer

Watch On Demand Here 


June 23, 2021  

Highlighting genomic testing in prostate cancer


  • Newly diagnosed high grade, high risk PC
  • Heavily treated, mCRPC

Watch On Demand here

July 21, 2021  at 5 PM ET 


  • BCG-Unresponsive, Non-Muscle Invasive Bladder Cancer
  • Muscle Invasive Bladder treated with neoadjuvant therapy, at cystectomy node+ disease

On demand link coming soon 


Learn more about the Urology Times Around the Practice series here.